Data as of Dec 11
| -0.25 / -0.52%|
The 14 analysts offering 12-month price forecasts for Incyte Corp have a median target of 46.50, with a high estimate of 56.00 and a low estimate of 14.00. The median estimate represents a -2.25% decrease from the last price of 47.57.
The current consensus among 16 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.